联合治疗 (UTHR.O)

+ 收藏

利润表(联合治疗)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2021年年报2021年三季报2021年中报2021年一季报2020年年报2020年三季报2020年中报2020年一季报
起始日期 2021-01-012021-01-012021-01-012021-01-012020-01-012020-01-012020-01-012020-01-01
截止日期 2021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-31
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表合并报表
报表年结日 12311231123112311231123112311231
原始币种 美元美元美元美元美元美元美元美元
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后上市后
营业收入(元) 1,685,500,000.001,270,300,000.00825,600,000.00379,100,000.001,483,300,000.001,098,400,000.00718,300,000.00356,300,000.00
 主营收入(元) 1,685,500,000.001,270,300,000.00825,600,000.00379,100,000.001,483,300,000.001,098,400,000.00718,300,000.00356,300,000.00
营业成本(元) 122,500,000.0087,900,000.0060,200,000.0023,000,000.00108,100,000.0073,300,000.0049,300,000.0023,400,000.00
毛利(元) 1,563,000,000.001,182,400,000.00765,400,000.00356,100,000.001,375,200,000.001,025,100,000.00669,000,000.00332,900,000.00
减:研发费用(元) 540,100,000.00457,200,000.00378,000,000.00303,700,000.00357,700,000.00231,600,000.00162,900,000.0073,200,000.00
减:营销费用(元) 467,000,000.00339,100,000.00230,000,000.00117,200,000.00423,900,000.00265,200,000.00198,900,000.0093,000,000.00
营业利润(元) 555,900,000.00386,100,000.00157,400,000.00-64,800,000.00593,600,000.00528,300,000.00307,200,000.00166,700,000.00
加:利息收入(元) 16,700,000.0012,500,000.008,700,000.004,700,000.0028,600,000.0023,600,000.0017,200,000.0010,000,000.00
加:利息支出(元) -18,600,000.00-13,900,000.00-9,300,000.00-4,600,000.00-23,500,000.00-18,700,000.00-13,800,000.00-8,200,000.00
加:投资性减值准备(元) -2,300,000.00-2,300,000.00-2,300,000.00--9,100,000.00-9,100,000.00-5,600,000.00-5,600,000.00
加:其他收入(支出)(元) 42,200,000.0071,000,000.0094,500,000.0097,200,000.0049,300,000.00400,000.00500,000.008,700,000.00
持续经营税前利润(元) 593,900,000.00453,400,000.00249,000,000.0032,500,000.00638,900,000.00524,500,000.00305,500,000.00171,600,000.00
减:所得税(元) 118,100,000.0089,800,000.0048,100,000.004,200,000.00124,100,000.00108,500,000.0060,700,000.0033,900,000.00
持续经营净利润(元) 475,800,000.00363,600,000.00200,900,000.0028,300,000.00514,800,000.00416,000,000.00244,800,000.00137,700,000.00
净利润(元) 475,800,000.00363,600,000.00200,900,000.0028,300,000.00514,800,000.00416,000,000.00244,800,000.00137,700,000.00
归属于母公司股东净利润(元) 475,800,000.00363,600,000.00200,900,000.0028,300,000.00514,800,000.00416,000,000.00244,800,000.00137,700,000.00
归属于普通股股东净利润(元) 475,800,000.00363,600,000.00200,900,000.0028,300,000.00514,800,000.00416,000,000.00244,800,000.00137,700,000.00
每股收益
 基本每股收益-普通股(元) 10.608.124.490.6311.659.435.563.14
 摊薄每股收益-普通股(元) 10.067.724.280.6111.549.375.533.12
其他全面收益(元) -8,800,000.00-5,900,000.00-4,400,000.00-2,600,000.00-9,700,000.0012,100,000.0010,700,000.00
全面收益总额(元) 467,000,000.00357,700,000.00196,500,000.0025,700,000.00514,800,000.00425,700,000.00256,900,000.00148,400,000.00
公告日期 2022-02-242021-11-032021-08-042021-05-052021-02-242020-10-282020-07-292020-04-29
会计准则 美国会计准则美国会计准则美国会计准则美国会计准则美国会计准则美国会计准则美国会计准则美国会计准则
审计意见
核数师

前瞻产业研究院